STREPTASE 1500000UI lyophilized for injection / infusion solution medication leaflet

B01AD01 streptokinase • Blood and blood forming organs | Antithrombotic agents | Enzymes

Streptokinase is a thrombolytic medication used to dissolve blood clots in cases of acute myocardial infarction, pulmonary embolism, or deep vein thrombosis. It works by activating plasminogen, which breaks down fibrin in clots.

The medication is administered intravenously under strict medical supervision, usually in intensive care units. It is important for patients to be monitored to prevent complications such as excessive bleeding.

Patients should be aware of potential side effects, such as allergic reactions, fever, or hypotension. It is important to inform the doctor of any unusual symptoms.

Common side effects include fever, hypotension, and allergic reactions. In rare cases, severe bleeding or anaphylactic reactions may occur. Patients should be informed of these risks before administration.

General data about STREPTASE 1500000UI

Substance: streptokinase

Date of last drug list: 01-07-2013

Commercial code: W10030001

Concentration: 1500000UI

Pharmaceutical form: lyophilized for injection / infusion solution

Quantity: 1

Product type: original

Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.

Concentrations available for streptokinase

1500000UI, 250000UI, 750000ui